Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2007
04/03/2007US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
04/03/2007US7199284 Chlorophyllases
04/03/2007US7199283 Nucleotide sequences coding polypeptide is used to transform a cell, produce a transgenic seeds, plants; carotenoid biosynthesis, coloring agent in poultry feed; use in the evaluating herbicides
04/03/2007US7199279 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools
04/03/2007US7199236 Deprotecting nucleotides having phosphotriester or phosphorodithioate linkages and at least one cyanoethyl protecting group by reaction with an amine deprotecting agent; solid phase synthesis
04/03/2007US7199235 Nucleotide sequences for use regulatory control tools in callus specific expression of heterologous gene sequences in plants; bioreactor; tissue engineering
04/03/2007US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents
04/03/2007US7199233 Artificial promoter libraries for selected organisms and promoters derived from such libraries
04/03/2007US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/03/2007US7199231 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
04/03/2007US7199230 Isolated from Streptomyces cinnamoneus; used to make lantibiotic duramycin; producing the preduramycin, produramycin or mature duramycin peptides
04/03/2007US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents
04/03/2007US7199227 Small modulators of HDAC activity, e.g., antagonists, inhibitors used to treat neoplastic cells; polynucleotide sequences, vectors, host cells; antiproliferation, -tumor and -carcinogenic agents, especially breast and prostate cancers
04/03/2007US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering
04/03/2007US7199109 Potent inhibition of influenza virus by specifically designed short interfering RNA
04/03/2007US7199107 Inhibiting synthesis and function; arresting cellular proliferation
04/03/2007US7198949 Compositions and methods for altering the biodistribution of biological agents
04/03/2007US7198943 Waste liquor of L-glutamic acid fermentation, which is usable as a raw material for a fertilizer
04/03/2007US7198937 oleaginous yeast that accumulates oils enriched in long-chain omega -3 and/or omega -6 polyunsaturated fatty acids; comprises chimeric nucleic acid molecule encoding a diacylglycerol acyltransferase 2 enzyme
04/03/2007US7198933 Comprises enzymatic protein for conversion of glucose to fructose; food processing; high fructose corn syrup
04/03/2007US7198929 Nucleotide sequences coding eukaryotic initiation factor-2 kinase for use in the identification of modulators which prevent and treat viral and liver disorders
04/03/2007US7198928 Human COX-1 alternatively spliced variants and methods of using same
04/03/2007US7198926 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids
04/03/2007US7198921 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
04/03/2007US7198920 HER-2/neu fusion proteins
04/03/2007US7198917 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
04/03/2007US7198916 Nucleotide sequences coding mutated fluorescent protein for use as improved diagnostic indicator in genetic engineering
04/03/2007US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
04/03/2007US7198912 Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39
04/03/2007US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
04/03/2007US7198900 forming at least one molecular complex comprising at least one analyte and at least one first probe comprising at least one reaction portion and at least one identity portion comprising at least one coded molecular tag
04/03/2007US7198897 Late-PCR
04/03/2007US7198893 DNA diagnostics based on mass spectrometry
04/03/2007US7198784 Retroviral vectors
04/03/2007CA2328447C Adeno-associated virus vectors and uses thereof
04/03/2007CA2193365C Polynucleotide vaccine for papillomavirus
04/03/2007CA2162397C Ligands for flt3 receptors
04/03/2007CA2103195C Method for the production of proteins in plant fluids
04/03/2007CA2094495C Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates
04/03/2007CA2089080C Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
04/03/2007CA1341524C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process
03/2007
03/29/2007WO2007035922A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
03/29/2007WO2007035814A2 Reagents, methods and kits for classification of fungi and direction of anti-fungal therapy
03/29/2007WO2007035759A1 Modulation of glucocorticoid receptor expression
03/29/2007WO2007033587A1 A method for isolating a bi-directional gene promotor and the use thereof
03/29/2007WO2007012494B1 Stable nad/nadh derivatives
03/29/2007WO2006131677A3 Method for breast cancer diagnosis/prognosis
03/29/2007WO2006130716A3 Method of inhibiting intimal hyperplasia
03/29/2007WO2006121664A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
03/29/2007WO2006088490A3 Oligonucleotides comprising a non-phosphate backbone linkage
03/29/2007WO2006088445A3 Metabolic primers for the detection of (per)chlorate-reducing bacteria and methods of use thereof
03/29/2007WO2006081537A3 Novel aromatic prenyltransferases, nucleic acids encoding same and uses therefor
03/29/2007WO2005074524A3 Modified human interferon polypeptides and their uses
03/29/2007WO2005053811A3 Biomolecule partition motifs and uses thereof
03/29/2007WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
03/29/2007WO2004081197A3 Immune response associated proteins
03/29/2007US20070074314 Vectors and methods for improved plant transformation efficiency
03/29/2007US20070074313 Native antibiotic resistance genes
03/29/2007US20070074311 Compositions and methods for modulating expression of gene products
03/29/2007US20070074310 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
03/29/2007US20070074309 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent
03/29/2007US20070074308 Useful in protecting plants from insect damage; also included are micro-organisms and plants transformed with DNA sequence encoding an insecticidal Cry1Bf protein to obtain a plant resistant to insects
03/29/2007US20070074307 Citrus tristeza virus resistance genes and methods of use
03/29/2007US20070074306 Plant transcriptional activator and uses thereof
03/29/2007US20070074305 nucleic acid molecule comprising a first nucleic acid segment encoding a polypeptide, and a second nucleic acid segment for suppression of a polypeptide involved in altering oleic acid content in a plant cell
03/29/2007US20070074296 RTD receptor
03/29/2007US20070074295 Schizophrenia related gene
03/29/2007US20070073049 Method and apparatus for nucleic purification using ion-permeable polymer-coated electrode
03/29/2007US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4
03/29/2007US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
03/29/2007US20070073043 Process for producing humanized chimera antibody
03/29/2007US20070073041 Human tumor necrosis factor receptor polypeptides
03/29/2007US20070073040 Anti-obesity polypeptides
03/29/2007US20070072823 siRNA targeting survivin
03/29/2007US20070072797 Epitopes
03/29/2007US20070072796 Oligonucleotide analogues incorporating 5-aza-cytosine therein
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072296 C/EBPalpha gene targeting constructs and uses thereof
03/29/2007US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof
03/29/2007US20070072278 Reductase gene and use thereof
03/29/2007US20070072274 Nucleic acids, expression vectors, host cells, and improved exogenous gene expression in microorganisms; amino acid biosynthesis of fine chemicals
03/29/2007US20070072273 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins)
03/29/2007US20070072271 Method for the production of recombinant proteins
03/29/2007US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide
03/29/2007US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same
03/29/2007US20070072268 Sulfotransferase and DNA encoding the enzyme
03/29/2007US20070072267 Transformant having galactose induction system and use thereof
03/29/2007US20070072265 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides
03/29/2007US20070072264 Recombinant chimeric acetylcholine receptors and their derivatives recognized by cd4 t cells of myasthenic patients for the treatment of myasthenia gravis
03/29/2007US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog
03/29/2007US20070072262 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2)
03/29/2007US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
03/29/2007US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
03/29/2007US20070072259 Fluorescent protein
03/29/2007US20070072249 Human cytokine and alpha-helix-containing polypeptides
03/29/2007US20070072247 Methods and reagents for the analysis and purification of polysaccharides
03/29/2007US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein
03/29/2007US20070072238 Wnt-frizzled chimera
03/29/2007US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors
03/29/2007US20070072231 Tumor suppressor gene